Samil Pharmaceutical Co.,Ltd (KRX: 000520)

Samil Pharmaceutical Co.,Ltd Revenue

Samil Pharmaceutical Co.,Ltd had revenue of 54.29B KRW in the quarter ending June 30, 2024, with 12.03% growth. This brings the company's revenue in the last twelve months to 210.73B, up 15.12% year-over-year. In the year 2023, Samil Pharmaceutical Co.,Ltd had annual revenue of 196.35B with 9.28% growth.

• Revenue (ttm): 210.73B
• Revenue Growth: +15.12%
• P/S Ratio: 0.95
• Revenue / Employee: 359.61M
• Employees: 586
• Market Cap: 272.95B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	196.35B	16.67B	9.28%
Dec 31, 2022	179.68B	45.43B	33.84%
Dec 31, 2021	134.25B	11.25B	9.14%
Dec 31, 2020	123.00B	1.89B	1.56%
Dec 31, 2019	121.11B	26.51B	28.02%